Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study

被引：3
|
作者：
Di Bona, Danilo [1 ]
Nettis, Eustachio [1 ]
Minenna, Elena [2 ]
Lovecchio, Antonella [1 ]
Paolino, Donato [1 ]
Cristina Nizi, Maria [3 ]
Albanesi, Marcello [1 ]
Ridolo, Erminia [3 ]
Filomena Caiaffa, Maria [2 ]
Macchia, Luigi [1 ]
机构：
[1] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sch & Chair Allergol & Clin Immunol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[2] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[3] Univ Parma, Med & Surg Dept, Allergy & Clin Immunol, Parma, Italy
来源：
ALLERGY | 2020年 / 75卷 / 10期
关键词：
URTICARIA;
D O I：
10.1111/all.14341
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2681 / 2684
页数：4
相关论文
共 50 条
  • [41] Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
    Calzari, Paolo
    Chiei Gallo, Alessandra
    Barei, Francesca
    Bono, Eleonora
    Cugno, Massimo
    Marzano, Angelo Valerio
    Ferrucci, Silvia Mariel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [42] Real-life 2-year therapeutic strategies in the management of 525 small-cell lung cancers (SCLCs) in French general hospitals.
    Debieuvre, Didier
    Goupil, Francois
    Brun, Philippe
    Diximier, Adrien
    De Faverges, Geoffroy
    Nocent-Ejnaini, Cecilia
    Crequit, Jacky
    Sylvie, Vuillermoz Blas
    Perrin, Christophe
    Leleu, Olivier
    Carbonnelle, Michel
    Asselain, Bernard
    Blanchon, Francois
    Martin, Francis
    Grivaux, Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [43] Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study
    Leo, Francesco
    Ortoncelli, Michela
    Cascio Ingurgio, Ruggero
    Galli, Benedetta
    Grigolato, Laura
    Paganini, Claudia
    Maurelli, Martina
    Di Brizzi, Eugenia Veronica
    Lauletta, Giuseppe
    Barei, Francesca
    Fiasconaro, Chiara Anna
    Casale Alloa, Marta
    Guanti, Mario Bruno
    Gori, Niccolo
    Chiricozzi, Andrea
    Napolitano, Maddalena
    Patruno, Cataldo
    Galluzzo, Marco
    Rossi, Mariateresa
    Balato, Anna
    Ferrucci, Silvia Mariel
    Marzano, Angelo Valerio
    Pezzolo, Elena
    Foti, Caterina
    Girolomoni, Giampiero
    Gargiulo, Luigi
    Narcisi, Alessandra
    Quaglino, Pietro
    Ribero, Simone
    Mastorino, Luca
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2025,
  • [44] Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE study
    Flipo, R. -M.
    Tubach, F.
    Goupille, P.
    Lespessailles, E.
    Harid, N.
    Sequeira, S.
    Bertin, P.
    Fautrel, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (03) : 537 - 545
  • [45] Vildagliptin Use in Elderly Type 2 Diabetes Mellitus Patients: Results from a 2-Year Observational Study in Real-Life Russian Clinical Settings
    Zilov, Alexey
    Shestakova, Marina
    DIABETES, 2013, 62 : A687 - A687
  • [46] Drug survival and predictor factors for discontinuation of methotrexate in psoriasis: a real-life multicenter study
    Ozkok Akbulut, Tugba
    Topaloglu Demir, Filiz
    Oguz Topal, Ilteris
    Kara Polat, Asude
    Karadag, Ayse Serap
    Aslan Kayiran, Melek
    Ozkur, Ezgi
    Kivanc Altunay, Ilknur
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : 1140 - 1147
  • [47] Clinical improvement in non-allergic patients treated with omalizumab in real-life: FENOMA study
    Cimbollek, S.
    Campo Mozo, P.
    Soto Campos, J. G.
    Moreira Jorge, A.
    Davila Gonzalez, I. J.
    ALLERGY, 2019, 74 : 299 - 300
  • [48] Impact of Visit Compliance on Response to Omalizumab Therapy in a Real-Life Clinical Setting: Reality Study
    Singh, Harjinder
    Peters, Jay
    Kaur, Yogeet
    Diaz, Joseph D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB13 - AB13
  • [49] Long-term efficacy and safety of omalizumab in patients with allergic asthma: A real-life study
    Papaioannou, Andriana, I
    Mplizou, Myrto
    Porpodis, Konstantinos
    Fouka, Evangelia
    Zervas, Eleftherios
    Samitas, Konstantinos
    Markatos, Miltiadis
    Bakakos, Petros
    Papiris, Spyridon
    Gaga, Mina
    Papakosta, Despoina
    Loukides, Stelios
    ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (03) : 235 - 242
  • [50] Real-life data on the effectiveness and safety of omalizumab in adolescents with chronic spontaneous urticaria: A retrospective study
    Guarracino, C.
    Tomasoni, A.
    Marseglia, A.
    Marseglia, G. L.
    Licari, A.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 : 79 - 79
12345